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Microsomal triglyceride transfer protein (MTTP) is an essential chaperone that assists in the assembly of apolipoprotein
B-containing lipoproteins to transport lipids. We have shown that microRNA (miR)-30c regulates MTTP expression but
other members of the same family do not. Further, we showed that interactions between miR-30c seed sequence and
the 3΄-untranslated region (UTR) of the MTTP mRNA are critical for this regulation. The same seed sequence is shared
by all the members of the miR-30 family. Therefore, it is unclear why only miR-30c regulates MTTP expression.
Bioinformatics analysis revealed that, miR-30c interacts with MTTP mRNA involving supplementary site, besides seed
sequence, forming an intervening loop. Here, we evaluated the importance of the supplementary site and the size of
the intervening loop in miR-30c/MTTP mRNA interactions by cloning MTTP 3΄-UTR at the end of the luciferase gene
and subjecting it to site-directed mutagenesis. Reducing the number of base pairs at the supplementary site abolished
the ability of miR-30c to reduce luciferase activity. However, increasing the number of base pairs at the supplementary
site, seed sequence or in the intervening loop enhanced the efficacy of miR-30c in reducing luciferase activity. These
studies demonstrated that the supplementary site of miR-30c is, but the intervening loop is not, critical for binding to
the MTTP mRNA. To our knowledge, this is the first demonstration that miRs might require both seed and
supplementary interactions to regulate target mRNA specificity. Further, this study suggests that more potent miR-30c
mimics could be synthesized by increasing base pairing in the loop region.
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The lipoprotein secretion pathway is controlled by two
critical factors: MTTP and apolipoprotein B (apoB) [1].
MTTP serves as a chaperone in the proper assembly
and secretion of apoB-containing lipoproteins. The sig-
nificance of MTTP was initially revealed in a condition
called abetalipoproteinemia [2]. These patients have null
mutations in the MTTP gene and exhibit virtually no
plasma apoB lipoproteins [3,4]. This discovery highlighted
the importance of MTTP in the lipoprotein assembly and
secretion pathway and suggested the possibility that its
inhibition might be useful in reducing plasma lipids.* Correspondence: mahmood.hussain@downstate.edu
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distribution, and reproduction in any mediumSubsequently, several chemical inhibitors of MTTP have
been developed. These antagonists successfully block
MTTP activity and lower plasma lipids. However, they also
cause hepatic steatosis and increase plasma transaminases
[5,6]. Hence, attempts are underway to target MTTP while
avoiding adverse effects associated with lowering plasma
lipids. Several approaches have been proposed to inhibit
MTTP while avoiding toxicity [7]. It has been suggested
that toxicity associated with MTTP inhibition is mainly
related to accumulation of lipids in the liver [8]. There-
fore, a combined use of MTTP inhibition with agents that
lower hepatic lipids might be useful. Further, intestine-
specific MTTP antagonists have been designed to circum-
vent unwanted side effects associated with hepatic MTTP
inhibition [9].
Recently, microRNAs (miRs) have emerged as novel
therapeutic agents. For example, it has been shown that
inhibition of miR-33 reduces atherosclerosis by increasingtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tagonism has been used as a possible therapeutic option in
the treatment of Hepatitis C virus [12]. miRs are endogen-
ous ~22 nucleotide long RNAs that interact with various
mRNAs to modulate their translational efficiency and/or
their mRNA stability thereby modulating the amounts of
proteins synthesized. miRs interact with the 3΄-untrans-
lated regions (UTRs) of several target mRNAs involving
seed sequences. Since miRs interact with several mRNA,
they affect different metabolic pathways. Hence, miRs pro-
vide a novel opportunity to regulate pathways instead of in-
dividual target proteins.
Using bioinformatics database, TargetScan, we found
that the miR-30 family members could interact with the
3΄-UTR of MTTP approximately 89 bases away from the
stop codon [13]. Furthermore, the interaction sites in both
the MTTP 3΄-UTR and miR-30 family members were con-
served through evolution among vertebrates. Further ana-
lyses revealed that one member of the family, miR-30c,
reduced hepatic MTTP expression both in vitro and
in vivo [13], while the other members of the miR-30 family
did not reduce MTTP expression. Reductions in MTTP
expression were associated with decreases in plasma lipids
and atherosclerosis in different mouse models [13]. Here,
we wanted to know why only miR-30c regulates MTTP.
miR-30c seed sequence interacts with MTTP mRNA in-
volving 6 nucleotide base pairs [13] and is considered
“marginal” and not a “canonical” site for miR target inter-
actions [14,15]. Marginal site is defined as having six per-
fect matches at the seed sequence; canonical site refers
to at least seven perfect matches. Further, miR-30c has
an atypical supplementary base pairing site involving
seven base pairs. Based on this information, we hypothe-
sized that the specificity of interactions between miR-30c
and MTTP may be determined by specific supplemen-
tary interactions and the positioning of the loop between
seed and supplementary sites. We evaluated this hypoth-




The entire 3΄-UTR (1149 bp) of human MTTP mRNA
was amplified by PCR and cloned into psiCHECK2
(Promega) plasmid between Not1 and Xho1 restriction
sites. Site-directed mutagenesis was performed using
QuikChange II XL (Agilent Technologies) to produce
different mutations. Primers used for PCR amplification
and sequencing were designed using PrimerExpress 3.0.
In addition, mutagenesis primers were designed using
Agilent Technologies Primer Design software (https://
www.genomics.agilent.com/) (Table 1). Sequence identity
of all plasmid mutations were verified by Macrogen, Inc.,
sequencing services.Cell culture and transfection with plasmid DNA or miRs
COS-7 cells were cultured in DMEM supplemented with
10% FBS, 1% penicillin/streptomycin, amphotericin and 1%
glutamine. For luciferase plasmid transfections, approxi-
mately 1.2 × 106 COS-7 cells were plated in 100 mm tissue
culture plates and reverse transfected with 50 nM Scr (5΄-
UCACAACCUCCUAGAAAGAGUAGA) or miR-30c (5΄-
UGUAAACAUCCUACACUCUCAGC) using RNAiMAX
transfection reagent (Invitrogen). After ~ 17 hours, cells
were transferred to 24-well tissue culture plates (5 ×
105 cells/well) and reverse transfected using Lipofec-
tamine 2000 transfection reagent (Invitrogen) again with
psiCHECK2 plasmid (1 μg/well) carrying either wildtype or
mutant MTTP 3′-UTR sequences. Cells were incubated
for another 17 hours and collected for analysis and mea-
sured for luciferase activity.Luciferase assay
Transfected cells were washed with PBS two times and
incubated with 1× Passive Lysis Buffer (Promega). Incu-
bation with Passive Lysis Buffer was done for approxi-
mately 30 minutes at room temperature. Luciferase activity
was measured using a luminometer. LAR II and Stop-n-
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and Renilla luciferase activity, respectively.
Statistical analysis
Experiments were performed in triplicates and repeated at
least three times. Data are presented as mean ± standard
deviation. Statistical significance (p < 0.05) was determined
using one-way analysis of variance (One-Way ANOVA)
with GraphPad Prism software.
Results
Predicted interactions between miR-30 family members
and MTTP mRNA
We have previously shown that seed sequence is import-
ant for the regulation of MTTP by miR-30c as mutations
in this sequence in the MTTP mRNA abolishes the abil-
ity of miR-30c to reduce MTTP expression [13]. All the
miR-30 family members share the same seed sequence
and could form similar base pairs with the MTTP mRNA
(Figure 1). Yet, only miR-30c regulates MTTP mRNA
[13]. Reasons for this specificity are not obvious. Com-
parative analysis of the miR-30 family members and their
possible interactions with MTTP mRNA revealed that
these two molecules could form complementary base
pairing involving disparate “seed” and “supplementary”
sequences resulting in the formation of an intervening
asymmetric loop where 8 residues in miR-30c and 6 resi-
dues in MTTP mRNA do not form base pairs (Figure 1).
Besides miR-30c that forms 7 base pairs, miR-30b can
form five base pairs with MTTP mRNA in its supple-
mentary site and yet is unable to regulate MTTP ex-
pression [13]. Other miR-30 family members are notFigure 1 Predicted interactions between miR-30c family members an
different miR-30 family members and MTTP mRNA was performed using Ta
interaction sites between miR-30c family members and the MTTP mRNA. Vpredicted to form supplementary base pairs with MTTP
mRNA and do not generate a loop (Table 1). Thus, it is
possible that specificity of miR-30c might be secondary
to its ability to interact with MTTP mRNA at the sup-
plementary site.Supplementary site interactions are required for miR-30c
to regulate MTTP expression
To determine the importance of number of base pairs in
the supplementary site, we used a reporter plasmid
(psiCHECK2) with the entire 3′ -UTR of MTTP mRNA
subcloned after the stop codon of the Renilla luciferase
gene. Specific base pairs in the supplementary site that
are involved in miR-30c binding were mutated using site-
directed mutagenesis. We first designed two mutants,
MTTPG82A and MTTPA81U,G82A to reduce the number of
base pairs at the supplementary site between miR-30c
and MTTP mRNA and increase the size of the loop be-
tween seed and supplementary sites (Figure 2A). As antici-
pated, when miR-30c was transfected into cells expressing
luciferase activity with the wildtype (WT) MTTP 3΄-
UTR, the luciferase activity was significantly diminished
(Figure 2B). However, miR-30c was unable to reduce
luciferase activity compared to the Scr control when
MTTPG82A and MTTPA81U,G82A mutations were intro-
duced in the 3′-UTR region. Now, there was no significant
difference between Scr and miR-30c indicating that miR-
30c was unable to interact with the 3΄-UTR of MTTP.
These studies indicate that interactions of miR-30c with
A81 and G82 residues in the 3′-UTR of MTTP are critical
for miR-30c to reduce luciferase activity.d 3΄-untranslated region of the MTTP mRNA. Base pairing between
rgetScan. Red rectangles demarcate seed and supplementary
ertical lines indicate base pairings.
Figure 2 Supplementary site interactions are critical for the binding of miR-30c to the 3΄-untranslated region of MTTP mRNA.
(A) Interactions between wildtype (MTTP) and miR-30c are shown in the top. Next two structures show mutations introduced in the
MTTP 3΄-UTR as green letters and predicted consequences of these mutations on the base pairing with miR-30c. (B) Cos-7 cells were
first transfected with 50 nM of Scr or miR-30c. Next day cells were transferred to 6-well plates and transfected with 1 μg f wildtype
(WT) or different indicated mutants. After 24 h, cells were used to measure luciferase activity. Values in one WT sample was normalized
to one and other values were normalized to this value. There were no significant differences amongst different Scr groups. Significant
differences between Scr and miR-30c are shown as *. Significant differences between WT and mutant MTTP constructs are shown as #.
Mean ± SD, n = 3. **,## p < 0.01.
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effect on the efficacy of miR-30c
After determining that the supplementary site interactions
are important, we asked whether increasing the number of
base pairs in this region might increase the efficacy of miR-
30c. To test this hypothesis, we designed one mutant,
MTTPU75G to increase base pairing at the 3΄ end of miR-
30c (Figure 3A). Further, an additional mutant, MTTPU75G,C83U was designed to improve binding at both the 3′ and 5′
ends in the supplementary region. The MTTPU75G mutant
interacts with 3′-UTR of MTTP involving eight bases while
the MTTPU75G,C83U mutant forms nine base pairs at the
supplementary site. We anticipated that increasing the
number of base pairs in this region will increase the efficacy
of miR-30c leading to significantly greater reductions in lu-
ciferase activity. Surprisingly, we observed that the
Figure 3 Increasing base pairings at either ends of the supplementary site has no effect on miR-30c and MTTP 3΄-UTR. (A) Base pairings
between WT and different MTTP mutants and miR-30c are shown. Top row shows interactions between WT MTTP 3΄-UTR and miR-30c. The
bottom two rows show mutations (shown as green alphabets) introduced in the MTTP sequence and their consequences on interactions with
miR-30c. (B) Cos-7 cells were transfected with Scr or miR-30c as described in Methods and Figure 2. Subsequently, cells were transferred to other
wells and transfected with luciferase expressing plasmids harboring either WT MTTP 3΄-UTR or different mutants described in Panel A. Significant
differences between Scr and miR-30c are shown. Mean ± SD, n = 3. *p < 0.05, **p < 0.01.
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similar to the wildtype (Figure 3B). Hence, efficacy of
miR-30c cannot be improved by increasing single base
pairings at either ends of the supplementary site.
Reducing the loop size between seed and supplementary
sites enhances efficacy of miR-30c in reducing MTTP
expression
Next, we evaluated importance of the loop present
between the seed and supplementary sites for miR-
30c/MTTP mRNA interactions. We hypothesized that theasymmetric loop might be important in determining the
specificity and efficacy of miR-30c towards MTTP mRNA.
Thus, mutations that reduce the size of the loop might
result in the loss of miR-30c effect on luciferase expres-
sion. To test this, we designed three different mutants
that would lead to the formation of varying degrees of
shorter loops when miR-30c and MTTP mRNA interact
(Figure 4A). The mutant, MTTPG90U,C91A has a slightly
smaller loop due to increased interactions at the seed
sequence. The MTTPC85G,C88U mutant has mutations
within the loop that theoretically reduces the loop and
Figure 4 Increasing base pairing at the seed sequence and in the intervening loop enhances affinity between miR-30c and MTTP 3΄-UTR.
(A) Interactions between WT and different MTTP 3΄-UTR mutants and miR-30c are shown. (B) Cos-7 cells were transfected with 50 nM of Scr or miR-30c
as described in Figure 2 and Materials and Methods. Cells were then plated in different wells and transfected with plasmids expressing luciferase and
containing either WT or mutant MTTP 3΄-UTR. After 17 h, cells were used to measure luciferase activities. Significant differences between Scr and
miR-30c are shown. Mean ± SD, n = 3. *p < 0.05, **p < 0.01, ***p < 0.001.
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mutant has mutations that essentially extend the length
of the supplementary site interactions to twelve bases
with significantly reduced loop size. Surprisingly, all
these three mutants showed reduced reporter activity
in the presence of miR-30c than wildtype (Figure 4B)
suggesting that the mutants respond better to miR-30c
than the WT 3΄-UTR of MTTP. This suggests that size
of the loop is not critical for proper binding of miR-30c
to its target; rather, the closing of the loop improves its
efficacy. In future studies, the design of better mimics
to target MTTP mRNA may best be suited to close theFigure 5 Effect of different concentrations of mutants on their suscep
of miR-30c. For control, cells were transfected with 100 nM Scr. Subsequen
Comparisons were made at each miR-30c concentrations with WT MTTP. Masymmetrical loop next to the seed and/or supplemen-
tary sequences.
The major findings of the above studies were that redu-
cing base pairings in the supplementary site abolish the
effect of miR-30c whereas increasing these base pairings
by reducing the loop size increases the efficacy. To con-
firm these studies, we transfected cells with different in-
dicated amounts of plasmids in miR-30c expressing cells
and analyzed the luciferase activity (Figure 5). Consistent
with Figure 2, mutant MTTPA81U,G82A was unable to
reduce luciferase expression at all the concentrations
suggesting that these residues are critical for the effect oftibility to miR-30c. Cells were first transfected with different amounts
tly, cells were transfected with 1 μg of different indicated plasmids.
ean ± SD, n = 3. ##, P < 0.01.
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tendency to be more effective and reached statistical
significance at the highest concentration. These studies es-
tablish that interactions at the supplementary site are im-
portant for miR-30c to regulate MTTP expression. Further
they indicate that it might be possible to increase the effi-
cacy of miR-30c by enhancing base pair interactions be-
tween seed and supplementary sites.Discussion
We have previously shown that miR-30c lowers both
MTTP mRNA and protein levels, but other miR-30 fam-
ily members do not affect MTTP levels [13]. All the
miR-30 family members share a common seed sequence;
therefore, it was not clear why only miR-30c regulates
MTTP expression. The aim of this study was to find out
sequence elements that determine the specificity of miR-
30c toward MTTP mRNA. Comparative analysis of the
miR-30 family members and their possible interactions
with MTTP mRNA revealed that miR-30c could interact
with supplementary sequences that are disparate from
seed sequences, forming an asymmetric intervening loop
where residues in miR-30c and MTTP mRNA do not
form any hydrogen bonds. We have previously shown
that interaction of miR-30c through seed sequence is ne-
cessary to regulate MTTP expression [13]. Here, we stud-
ied the importance of supplementary site and intervening
loop in determining the specificity between miR-30c and
MTTP mRNA. When we reduced the number of base
pairs in the supplementary site, miR-30c lost its ability to
lower luciferase activity. In particular, MTTPG82 was crit-
ical for miR-30c binding to the 3′ -UTR of MTTP mRNA.
This was further confirmed by the use of MTTPA81U,G82A.
This mutant was also not responsive to miR-30c. The
mutant MTTPA81U,G82A is very similar to miR-30b. The
MTTPA81U,G82A mutant forms five base pairs with miR-
30c, just like miR-30b. We have previously shown that
miR-30b does not affect MTTP expression. Thus, these
studies indicate that a minimum of seven base pairs at
the supplementary site are required for miR-30c to regu-
late MTTP expression.
We also examined the 3′ end of the supplementary re-
gion to further understand the specific interactions of
miR-30c and MTTP. We designed a mutant that targeted
the 3΄ end (MTTPU75G) and one that targets both the 3′
and 5′ ends (MTTPU75G,C83U). The two mutants had no
additional effects on miR-30c binding to the 3′ UTR of
MTTP. This result was unexpected, as we had predicted
that increasing base pairing at the supplementary site
would improve binding efficacy. These data suggest that
increasing one base pair at the 3′ and 5΄-ends of the sup-
plementary region has no additive benefit in reducing
MTTP expression.Importance of the intervening loop was studied by in-
creasing base pairings at supplementary and seed se-
quences, and thereby reducing its size. Further, the loop
was interrupted by introducing base pairing within the
loop. Increasing supplementary interactions to 9 base
pairs as in MTTPC83U,A84G,C85U enhanced miR-30c effi-
cacy. Similarly increasing interactions by 2 base pairs at
the seed sequence also increased miR-30c efficacy as
seen in MTTPG90U,C91A. These data indicate that the size
of the intervening loop is not critical for the regulation
of MTTP expression by miR-30c. This was further sup-
ported by the observation that mutant MTTPC85U,C88G
that disrupts the loop and creates two small loops appears
to act better than the wildtype 3΄-UTR in responding to
miR-30c. Thus, increasing base pairing at the seed, supple-
mentary and loop enhances interactions of miR-30c with
3΄-UTR of MTTP mRNA. It is possible that miR-30c
mimics with enhanced binding in the intervening loop
region might be more potent than miR-30c in reducing
MTTP expression.
These studies clearly show that supplementary interac-
tions play a role in determining specificity and enhan-
cing binding between miR-30c and MTTP. Previously,
the importance of the interactions at the supplementary
site has not been fully appreciated perhaps because of
the lack of precise and strong predictive databases that
pair miRs with mRNA. Databases that analyze the sup-
plementary region based on free energy, secondary struc-
ture, and straightforward base pairing have revealed that
residues 13 to 17 may be critical for binding [16,17]. At-
tempts at analyzing the evolutionary conservation of the
supplementary binding sites has not added much to the
understanding of the importance of supplementary re-
gion [16]. Unlike the analyses of the seed sequence, ana-
lyzing the supplementary sequence may be more difficult
because of the sheer number of bases (more than seven)
and other energy requirements involved in predicting
binding sites. Furthermore, maintaining evolutionary con-
servation in the supplementary region may be more diffi-
cult due to energy constraints and the increased number of
base pairing involved. Despite the lack of strong predictive
databases to study the supplementary region, we have ex-
perimentally observed that miR-30c reduces MTTP ex-
pression while other members of the miR-30 family do not.
Therefore, these studies suggest that experimental valid-
ation is required on a case by case basis to establish the im-
portance of supplementary interactions between miRs and
their targets.
A caveat of this study is that we only mutated se-
quences in the 3΄-UTR of MTTP and did not make
complementary changes in the miR-30c. This is mainly
because we do not have expertise in synthesizing miR
mimics and the cost of custom synthesizing miR-30c
mimics is prohibitive. However, mutations generated in
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that perhaps can be more efficacious than miR-30c. These
studies suggest that attempts to design better miR-30c
mimics should focus to increase base pairing at the seed
sequence and closing the intervening loop between the
seed and supplementary sites. These changes might im-
prove affinity between miR-30c and MTTP 3΄-UTR and
lower amounts of miR-30c mimics needed to reduce
MTTP expression. However, care should be taken to
avoid creating a siRNA as MTTP antisense oligonucleo-
tides have not been very useful therapeutic agents [18].
Since bioinformatics algorithms are unavailable that can
analyze supplementary site interactions and predict regu-
lation of target mRNAs, there is a need to experimentally
determine whether newly designed miR-30c mimics that
have higher affinity for MTTP 3΄-UTR would regulate
lipid metabolic pathways similar to miR-30c and would
not lead to adverse events seen with MTTP inhibition.
Nevertheless, we can speculate that increasing inter-
actions between miR-30c and MTTP mRNA will pre-
serve the targeting of additional pathways by miR-30c
since these modifications will not alter seed sequence.
Improved binding of miR-30c mimics to MTTP mRNA
while maintaining the same level of regulation of other
lipid synthesis pathways could be the ideal therapeutic
modality.
Because of the stringent requirements for the regula-
tion of MTTP by miR-30c, it is possible that mutations
in the MTTP 3΄-UTR or in the miR-30c sequences could
have subtle effects on lipid metabolism. Hence, it might
be useful to determine whether mutations in miR-30c
gene(s) and/or MTTP 3΄-UTR could cause hyperlipid-
emia in humans. However, it should be pointed that mu-
tations in the seed sequence of miR-30c could have
unwanted consequences as this might affect interactions
with several other targets. But, mutations in the supple-
mentary site might have specific effects on MTP and lipid
metabolism.
A word of caution about the use of miR-30c mimics as
therapeutic target is that miR-30c, as other miRs, has sev-
eral other targets. Moreover, miR-30c has been shown to
promote adipocyte differentiation [19]. It remains to be de-
termined whether miR-30c therapy will be associated with
obesity. Intuitively, this might not occur as high miR-30c
concentrations will probably lower intestinal and hepatic
lipoprotein production and reduce plasma lipids. There-
fore, there will be fewer lipids available for storage in the
adipose tissue.
In short, these studies show that the specificity of miR-
30c, compared to other members of the miR-30 family, to-
wards MTTP mRNA might be in part due to additional
supplementary interactions. Further, these studies showed
that intervening loop between seed and supplementary
sites is not critical for miR-30c/MTTP mRNA interactions.Additionally, these studies suggest that increasing base
pairing in this region might be beneficial in designing a po-
tent miR-30c mimic.
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